cancer

December 30, 2024 4:58 PM

Study links coffee, tea consumption to reduced risk of head and neck cancer

A new study has revealed that drinking coffee and tea may significantly lower the risk of developing head and neck cancers, a group that includes cancers of the mouth, throat, and larynx. Published in the peer-reviewed journal CANCER by the American Cancer Society, the research sheds light on the potential protective effects of these widely consumed beverages. The pooled analysis, conducted by the International Head and Neck Cancer Epidemiology Consortium, combined data from 14 studies involvi...

December 23, 2024 8:06 PM

Coffee and Tea may reduce risk of head and neck cancer, study finds

Regular consumption of coffee and tea may help lower the risk of developing head and neck cancers, including cancers of the mouth and throat, according to a study published on Monday in the CANCER journal. These findings could hold significant implications for the global fight against one of the most prevalent forms of cancer. Head and neck cancer is the seventh most common type of cancer worldwide, with rising rates, particularly in low- and middle-income countries. The study analyzed data fro...

November 12, 2024 12:33 PM

New antibody shows promise as breakthrough cancer treatment: Study

Researchers at Uppsala University and KTH Royal Institute of Technology have developed an antibody that has the potential to treat various types of cancer. The researchers successfully integrated three different functionalities into the antibody, which significantly enhanced the action of T cells on cancer tumors. The researchers have created a unique type of antibody that both targets and delivers a drug package via the antibody itself, while simultaneously activating the immune system, in wha...

October 10, 2024 5:19 PM

Scientists discover key enzyme to overcome cancer drug resistance

Scientists from the Indian Association for the Cultivation of Science (IACS), Kolkata, have identified a new therapeutic target by activating a DNA repair enzyme called Tyrosyl-DNA phosphodiesterase 1 (TDP1). This discovery could pave the way for combination therapy, offering hope for patients who are resistant to existing cancer treatments. Current anticancer drugs like Camptothecin, Topotecan, and Irinotecan focus on inhibiting the enzyme Topoisomerase 1 (Top1), which is essential for DNA rep...

September 16, 2024 3:26 PM

GST rates slashed for certain cancer drugs, namkeens, shared helicopter service

In its meeting on Monday, the Goods and Services Tax (GST) Council announced several key decisions aimed at reducing tax burdens across various sectors. To alleviate the financial strain of cancer treatment, the Council slashed GST rates on certain cancer drugs from 12% to 5%. The drugs benefiting from this reduction are Trastuzumab Deruxtecan, Osimertinib, and Durvalumab. The food industry also saw relief as the GST rate on namkeens and savoury items was reduced from 18% to 12%, effective pro...

September 16, 2024 5:18 PM

Researchers reveals ways of preventing cancer cells from colonizing liver

Researchers at ETH Zurich have made a significant discovery in the fight against cancer metastasis, potentially paving the way for new treatments to prevent the spread of colorectal cancer to the liver. In a study published today in Nature, a team led by Andreas Moor from the Department of Biosystems Science and Engineering at ETH Zurich's Basel campus has identified key molecular mechanisms that allow colorectal cancer cells to colonize the liver. "Nine times out of ten, metastasis is the cau...

July 8, 2024 6:59 PM

Study identifies thousands of high-risk cancer gene variants

Scientists have made a groundbreaking discovery, identifying over 5,000 genetic variations that contribute to cancer growth. This landmark study, conducted by researchers from the Wellcome Sanger Institute, The Institute of Cancer Research, London, and the University of Cambridge, also uncovered a potential therapeutic target for treating and possibly preventing certain cancers. The research, published in Nature Genetics, focused on the BAP1 gene, known as a 'tumor defense' gene. Using an innov...

July 4, 2024 9:03 PM

Study finds chemo medicine may cause significant hearing loss in longtime cancer survivors

A new study has revealed that a common chemotherapy drug may cause significant hearing loss in cancer survivors years after treatment. The research, published in the Journal of the American Medical Association Oncology, followed testicular cancer survivors who received cisplatin-based chemotherapy for an average of 14 years. The study found that 78% of survivors experienced significant difficulties in everyday listening situations, which negatively impacted their quality of life. Cisplatin, wid...

June 26, 2024 5:36 PM

New Israeli MRI Technique Offers Hope for Early Pancreatic Cancer Detection

Scientists at the Weizmann Institute of Science have developed a groundbreaking magnetic resonance imaging (MRI) technique that could revolutionize the early detection of pancreatic cancer, one of the deadliest forms of the disease. The innovative method, detailed in a recent issue of Science Advances, leverages the unique way cancer cells metabolize glucose to illuminate tumors that are often invisible to conventional imaging techniques. Pancreatic cancer, while relatively rare, is projected ...

May 1, 2024 1:47 PM

Breast cancer screening should begin at age 40, US panel says

Women at average risk for breast cancer should get screening mammograms every other year starting at age 40, the U.S. Preventive Services Task Force (USPSTF) said on Tuesday, cementing insurance coverage for the procedure for that age group under the law. The USPSTF's influential recommendation, published in JAMA, reverses its controversial 2009 guidance that breast cancer screening should begin at age 50. Its updated guidelines bring it in line with other major organizations that say women at...